The PEERLESS Study (PEERLESS)
view all Clinical Trials
Overview
A prospective, multicenter, randomized controlled trial of the FlowTriever System compared to Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute pulmonary embolism. The trial includes a non-randomized cohort of subjects with an absolute contraindication to thrombolysis.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.